IMMUNIC, INC. — Director's Dealing 2019

Aug 5, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUNIC, INC. (IMUX)
CIK: 0001280776
Period of Report: 2019-08-01

Reporting Person: Groeppel Manfred (Chief Operating Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-08-01	Stock Option	$13.29	A	20000	Acquired	2029-08-01	Common Stock (20000)	Direct

Footnotes

F1: 5,000 of the options vest on the one-year anniversary of the grant date. Thereafter, 440 of the options vest on the thirteen (13) month anniversary of the grant date, and 416 of the options vest on each successive one-month anniversary thereafter for the next thirty five (35) months.